Results 271 to 280 of about 15,139,370 (299)
Some of the next articles are maybe not open access.

Microbiota and immune-related adverse events in cancer immunotherapy

Nature Reviews Cancer
In response to treatment with immune checkpoint inhibitors (ICIs), patients with cancer can develop immune-related adverse events (irAEs), which are off-target toxicities affecting non-tumour tissues. Development of an irAE can require cessation of ICI treatment and cause additional morbidities, unrelated to cancer.
Sarah M. Schneider   +4 more
openaire   +2 more sources

Hypophysitis: Nursing Management of Immune-Related Adverse Events

Clinical Journal of Oncology Nursing, 2017
Immunotherapy can treat cancer and prevent future cancer relapse by enhancing the body's immune system. With novel immunotherapeutic agents like checkpoint inhibitors come unique immune-related adverse events. Hypophysitis, one of the lesser known immune-related complications, may be observed in patients receiving checkpoint inhibitors.
openaire   +2 more sources

The Current and Future of Biomarkers of Immune Related Adverse Events

Immunology and Allergy Clinics of North America
With their groundbreaking clinical responses, immune checkpoint inhibitors (ICIs) have ushered in a new chapter in cancer therapeutics. However, they are often associated with life-threatening or organ-threatening autoimmune/autoinflammatory phenomena, collectively termed immune-related adverse events (irAEs). In this review, we will first describe the
William, Bracamonte-Baran, Sang T, Kim
openaire   +3 more sources

Patient Voices in Rheumatic Immune-related Adverse Events

Rheumatic Disease Clinics of North America
Patients with cancer considering immune checkpoint inhibitor (ICI) therapy often look for health information and peer support through online communities. The authors used social media content analysis to obtain the perspectives of patients receiving ICI treatment about immune-related adverse events (irAEs), with particular focus on rheumatological ...
Kara N, Corps   +2 more
openaire   +2 more sources

[Management of immune-related adverse events].

Urologie (Heidelberg, Germany)
With the implementation of immunotherapy, a completely new, broad spectrum of side effects has emerged in oncology-the immune-related adverse events (irAEs). Their management differs greatly from that of classic cytotoxic side effects and is based primarily on corticosteroids, immunomodulatory agents, and treatment interruptions.
Marika Henriette, Princk   +2 more
openaire   +1 more source

A Review of Cancer Immunotherapy Toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Immune-related cutaneous adverse events

Annals of Allergy, Asthma & Immunology, 2021
openaire   +1 more source

Moving Towards Personalized Treatments of Immune-Related Adverse Events

Nature Reviews Clinical Oncology, 2020
Marie Hudson   +2 more
exaly  

Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events

Journal of Thoracic Oncology, 2021
Bianca D Santomasso   +2 more
exaly  

Home - About - Disclaimer - Privacy